Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medaxonum, 250 mg, powder for solution for injection/infusion.
Medaxonum, 500 mg, powder for solution for injection/infusion.
Medaxonum, 1 g, powder for solution for injection/infusion.
Medaxonum, 2 g, powder for solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. Almost white or yellowish crystalline powder. |
Medaxonum 250 mg vials contain 250 mg ceftriaxone as hydrated ceftriaxone disodium.
Medaxonum 500 mg vials contain 500 mg ceftriaxone as hydrated ceftriaxone disodium.
Medaxonum1 g vials contain 1 g ceftriaxone as hydrated ceftriaxone disodium.
Medaxonum 2 g vials contain 2 g ceftriaxone as hydrated ceftriaxone disodium.
| Active Ingredient | Description | |
|---|---|---|
| Ceftriaxone |
Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death. |
| List of Excipients |
|---|
|
None. |
Medaxonum250 mg, Medaxonum 500 mg, and Medaxonum 1 g are supplied in clear type I glass vials, nominal capacity 10 ml, sealed with a 20 mm diameter grey bromobutyl rubber stopper and aluminium overcap, in a carton with a leaflet.
Medaxonum 2 g are clear type I glass vials having a nominal capacity of 20 ml sealed with a 20 mm rubber stoppers and an aluminium cap.
Cartons containing 1, 10, 50, or 100 vials are available for Medaxonum" 250 mg,
Medaxonum 500 mg, and Medaxonum 1 g.
Cartons containing 1, 10, 25, 50, or 100 vials are available for Medaxonum 2g.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medaxonum, 250 mg: 18562
Medaxonum, 500 mg: 18563
Medaxonum, 1 g: 18561
Medaxonum, 2 g: 20741
Medaxonum, 250 mg: 2/2/2000
Medaxonum, 500 mg: 2/2/2000
Medaxonum, 1 g: 2/2/2000
Medaxonum, 2 g: 02/08/2010
| Drug | Countries | |
|---|---|---|
| MEDAXONUM | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
